Genzyme Settles For $32.5 Million With DOJ Over Unlawful Distribution
This article was originally published in The Gray Sheet
Executive Summary
Genzyme, a subsidiary of Sanofi, agreed to settle for $32.5 million unlawful distribution charges with the Department of Justice on Sept. 3, based on allegations that Genzyme sale reps taught surgeons how to mix the firm’s Seprafilm into a liquid slurry for application in surgeries – an unapproved use.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.